Journal of Autoimmunity

Papers
(The TQCC of Journal of Autoimmunity is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak3301
The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China612
Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?538
The etiology of rheumatoid arthritis358
The 2022 outbreak and the pathobiology of the monkeypox virus270
Autoinflammatory and autoimmune conditions at the crossroad of COVID-19229
Assessing ACE2 expression patterns in lung tissues in the pathogenesis of COVID-19212
Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses202
Omicron SARS-CoV-2 variant: Unique features and their impact on pre-existing antibodies166
An overview of autoantibodies in rheumatoid arthritis161
Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience161
Complement activation and endothelial perturbation parallel COVID-19 severity and activity121
Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection118
The pathogenesis, diagnosis and clinical manifestations of steroid-induced osteonecrosis115
Systemic autoinflammatory diseases108
Treg cells in health and autoimmune diseases: New insights from single cell analysis106
Inflammatory markers in systemic lupus erythematosus100
Mitigating Covid-19 in the face of emerging virus variants, breakthrough infections and vaccine hesitancy95
Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy94
COVID-19 convalescent plasma composition and immunological effects in severe patients90
The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-1990
Ferritin – from iron, through inflammation and autoimmunity, to COVID-1987
Autoimmune hepatitis triggered by SARS-CoV-2 vaccination85
The pathogenesis of systemic lupus erythematosus: Harnessing big data to understand the molecular basis of lupus85
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients’ subgroups83
SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients83
The immunobiology of mTOR in autoimmunity77
Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity?73
Sjögren's syndrome: Old and new therapeutic targets73
Auto-immune hepatitis following COVID vaccination71
Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients68
The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 – A systematic review of the literature68
Autoimmune hepatitis after COVID-19 vaccine – more than a coincidence68
A case of Graves' disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination62
Clinical significance of miRNAs in autoimmunity62
Precision medicine and management of rheumatoid arthritis56
Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-1954
Clinical characteristics and predictors of survival in adults with coronavirus disease 2019 receiving tocilizumab53
Safety and efficacy of fecal microbiota transplantation for treatment of systemic lupus erythematosus: An EXPLORER trial53
Autoimmune hepatitis after SARS-CoV-2 vaccine: New-onset or flare-up?53
The roles of PPARγ and its agonists in autoimmune diseases: A comprehensive review52
Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data51
Marginal zone B cells: From housekeeping function to autoimmunity?49
Innate immunity as the trigger of systemic autoimmune diseases49
The progress and prospect of regulatory T cells in autoimmune diseases49
JAK/STAT signaling controls the fate of CD8+CD103+ tissue-resident memory T cell in lupus nephritis47
Recent advances in the NEK7-licensed NLRP3 inflammasome activation: Mechanisms, role in diseases and related inhibitors46
Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: A retrospective cohort study45
Resistant starch intake alleviates collagen-induced arthritis in mice by modulating gut microbiota and promoting concomitant propionate production45
A prospective multicenter study assessing humoral immunogenicity and safety of the mRNA SARS-CoV-2 vaccines in Greek patients with systemic autoimmune and autoinflammatory rheumatic diseases44
Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review43
Perspectives on vaccine induced thrombotic thrombocytopenia43
Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-1943
Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: An analysis of European data42
High dose subcutaneous Anakinra to treat acute respiratory distress syndrome secondary to cytokine storm syndrome among severely ill COVID-19 patients42
Coronavirus disease 2019, immune-mediated inflammatory diseases and immunosuppressive therapies – A Danish population-based cohort study40
Abnormalities of T cells in systemic lupus erythematosus: new insights in pathogenesis and therapeutic strategies40
Autoantibodies to neutrophil extracellular traps represent a potential serological biomarker in rheumatoid arthritis40
Cardiovascular disease risk in antiphospholipid syndrome: Thrombo-inflammation and atherothrombosis39
Mushrooms and immunity38
Extracellular vesicles and lupus nephritis - New insights into pathophysiology and clinical implications38
Lupus nephritis: new progress in diagnosis and treatment38
Evolving story of autoantibodies in systemic lupus erythematosus37
New developments implicating IL-21 in autoimmune disease36
Best practices for detection, assessment and management of suspected immune-mediated liver injury caused by immune checkpoint inhibitors during drug development36
Clinical disease activity and flare in SLE: Current concepts and novel biomarkers36
Durable antibody response one year after hospitalization for COVID-19: A longitudinal cohort study36
Leukocytoclastic vasculitis (cutaneous small-vessel vasculitis) after COVID-19 vaccination35
Regulatory T cells in autoimmune hepatitis: an updated overview35
Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines33
The pivotal role of CD69 in autoimmunity32
Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune hepatitis32
Short-chain fatty acid butyrate induces IL-10-producing B cells by regulating circadian-clock-related genes to ameliorate Sjögren's syndrome32
Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals31
Intestinal permeability in type 1 diabetes: An updated comprehensive overview30
Gene expression profiling of epithelium-associated FcRL4+ B cells in primary Sjögren's syndrome reveals a pathogenic signature29
Bi-directional communication: Conversations between fibroblasts and immune cells in systemic sclerosis29
An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-1929
Relapsed and newly diagnosed Graves’ disease due to immunization against COVID-19: A case series and review of the literature29
Comprehensive TCR repertoire analysis of CD4+ T-cell subsets in rheumatoid arthritis28
Mesenchymal stromal cells-derived extracellular vesicles alleviate systemic sclerosis via miR-29a-3p28
CXCL4 triggers monocytes and macrophages to produce PDGF-BB, culminating in fibroblast activation: Implications for systemic sclerosis27
Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus27
Pirfenidone alleviates lipopolysaccharide-induced lung injury by accentuating BAP31 regulation of ER stress and mitochondrial injury27
Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy27
Severe aplastic anemia after COVID-19 mRNA vaccination: Causality or coincidence?27
Corrigendum to “The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China” [J. Autoimmun. 109C (2020) 102434]27
Insights into the treatment of rheumatoid arthritis: A paradigm in medicine27
Cardiac involvement in adult-onset Still's disease: Manifestations, treatments and outcomes in a retrospective study of 28 patients27
Antagonizing miR-7 suppresses B cell hyperresponsiveness and inhibits lupus development27
Profiling of the immune repertoire in COVID-19 patients with mild, severe, convalescent, or retesting-positive status26
The complement system and human autoimmune diseases26
Microscopic polyangiitis: Clinical characteristics and long-term outcomes of 378 patients from the French Vasculitis Study Group Registry25
Multi-omics: Differential expression of IFN-γ results in distinctive mechanistic features linking chronic inflammation, gut dysbiosis, and autoimmune diseases25
Human gingiva-derived mesenchymal stem cells are therapeutic in lupus nephritis through targeting of CD39−CD73 signaling pathway25
Selective targeting of PI3Kδ suppresses human IL-17-producing T cells and innate-like lymphocytes and may be therapeutic for IL-17-mediated diseases25
Mutations in the monkeypox virus replication complex: Potential contributing factors to the 2022 outbreak25
Autoantibodies in systemic lupus erythematosus: From immunopathology to therapeutic target24
Prevention and cure: The major unmet needs in the management of rheumatoid arthritis24
Treat to target in axial spondyloarthritis: From its concept to its implementation24
A biomarker for lymphoma development in Sjogren's syndrome: Salivary gland focus score24
Autoimmune dysautonomia in women with silicone breast implants24
LAG3 (CD223) and autoimmunity: Emerging evidence24
Endoplasmic reticulum-associated degradation and beyond: The multitasking roles for HRD1 in immune regulation and autoimmunity23
Dendritic cells in systemic lupus erythematosus: From pathogenesis to therapeutic applications23
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort23
Insights into interplay of immunopathophysiological events and molecular mechanistic cascades in psoriasis and its associated comorbidities23
T helper cell immunity in pregnancy and influence on autoimmune disease progression23
Integrated bulk and single-cell RNA-sequencing identified disease-relevant monocytes and a gene network module underlying systemic sclerosis22
A multidisciplinary registry of patients with autoimmune and immune-mediated diseases with symptomatic COVID-19 from a single center22
Resident human dermal γδT-cells operate as stress-sentinels: Lessons from the hair follicle22
Early diagnosis and treatment for Sjögren's syndrome: current challenges, redefined disease stages and future prospects22
Mitochondrial N-formyl methionine peptides associate with disease activity as well as contribute to neutrophil activation in patients with rheumatoid arthritis22
Gut microbiota in systemic lupus erythematosus: A fuse and a solution22
Longitudinal analysis of T-cell receptor repertoires reveals persistence of antigen-driven CD4+ and CD8+ T-cell clusters in systemic sclerosis22
Monoclonal antibodies from B cells of patients with anti-MDA5 antibody-positive dermatomyositis directly stimulate interferon gamma production21
CD137 / CD137 ligand signalling regulates the immune balance: A potential target for novel immunotherapy of autoimmune diseases21
Pathogenesis, multi-omics research, and clinical treatment of psoriasis21
Association of the CXCL9-CXCR3 and CXCL13-CXCR5 axes with B-cell trafficking in giant cell arteritis and polymyalgia rheumatica21
Short term outcomes of COVID-19 in lupus: Propensity score matched analysis from a nationwide multi-centric research network21
Antiphospholipid antibodies can specifically target placental mitochondria and induce ROS production20
Prevalence of COVID infections in a population of rheumatic patients from Lombardy and Marche treated with biological drugs or small molecules: A multicentre retrospective study20
Transcriptome landscape of double negative T cells by single-cell RNA sequencing20
Insights into the knowledge of complex diseases: Environmental infectious/toxic agents as potential etiopathogenetic factors of systemic sclerosis20
Alteration of CD226/TIGIT immune checkpoint on T cells in the pathogenesis of primary Sjögren's syndrome19
Rituximab plus belimumab in non-infectious refractory cryoglobulinemia vasculitis: A pilot study19
High T-cell response rate after COVID-19 vaccination in belimumab and rituximab recipients19
Telomeres: New players in immune-mediated inflammatory diseases?19
COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review18
Galectin-9 bridges human B cells to vascular endothelium while programming regulatory pathways18
TLR expression profiles are a function of disease status in rheumatoid arthritis and experimental arthritis18
0.035683870315552